0001437749-24-007662.txt : 20240313 0001437749-24-007662.hdr.sgml : 20240313 20240313165224 ACCESSION NUMBER: 0001437749-24-007662 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240312 FILED AS OF DATE: 20240313 DATE AS OF CHANGE: 20240313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Charney Laurence N CENTRAL INDEX KEY: 0001407451 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 24746704 MAIL ADDRESS: STREET 1: MARVEL ENTERTAINMENT, INC. STREET 2: 417 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TG THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (212) 554-4484 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030310 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 rdgdoc.xml FORM 4 X0508 4 2024-03-12 0001001316 TG THERAPEUTICS, INC. TGTX 0001407451 Charney Laurence N 3020 CARRINGTON MILL BLVD, SUITE 475 MORRISVILLE NC 27560 1 0 Common Stock 2024-03-12 4 S 0 22000 15.97 D 215229 D These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations. Reflects the weighted average sale price. The range of prices for the shares sold was $15.95 to $16.00. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. Includes shares of restricted Common Stock, which vest over various time periods. /s/ Laurence N. Charney 2024-03-13